A Focus on Intratumoral Therapies, Vaccines, & Cytokines

Friday, March 10, 2023 | 2-6 P.M. CST
Hybrid | Virtual and Houston, TX

Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of intratumoral therapies, vaccines, & cytokines.

Register Now

Program Organizers

Adi Diab, MD
The University of Texas MD Anderson Cancer Center

Greg Lizee, PhD
The University of Texas MD Anderson Cancer Center

Rahul A. Sheth, MD
The University of Texas MD Anderson Cancer Center

Program Agenda

1:55–2 p.m.



2-2:25 p.m.

  Cytokine Therapy: The Hype and Hope
Adi Diab, MD - The University of Texas MD Anderson Cancer Center

2:253:05 p.m.


Tumor Vaccines
Greg Lizee, PhD - The University of Texas MD Anderson Cancer Center

3:054:05 p.m.


Intratumoral Therapy

The Theory and The Practice
Rahul A. Sheth, MD - The University of Texas MD Anderson Cancer Center

Different Shades of “in Situ Activation”: The Oncolytic Approach
Dmitriy Zamarin, MD, PhD - Memorial Sloan Kettering Cancer Center

Different Shades of “in Situ Activation”: Small Molecules and Antibody Approach
Salah-Eddine Bentebibel, PhD - The University of Texas MD Anderson Cancer Center

4:05-4:35 p.m.



4:35–5:15 p.m.


Cancer Immunotherapy In Practice

Education and Resources
Michelle Rohlfs, NP, DNP, APRN, FNP-BC -The University of Texas MD Anderson Cancer Center

Systemic and Financial Toxicities
Van Anh Trinh, PharmD, BCOP – The University of Texas MD Anderson Cancer Center

5:156:15 p.m.


Faculty Panel

6:15 p.m.


Closing Remarks

Program Details

Venue information

Hilton Houston Plaza/Medical Center

6633 Travis St, Houston, TX 77030

The Hilton Houston Plaza / Medical Center is across the street from the Texas Medical Center and four blocks from Rice University, with free shuttle service to both campuses. It's also minutes from Dryden Metro Station, which links to downtown Houston, and NRG Stadium is two miles away. Enjoy the fitness center and take in city views from the rooftop pool and bar.

Program Learning Objectives

  • Describe the mechanisms of intratumoral therapies, vaccines, and cytokines.
  • Summarize recent updates in the use of intratumoral therapies, vaccines, and cytokines clinically.
  • Outline common toxicities with intratumoral therapies, vaccines and cytokines and their management.

Target Audience

The Advances in Cancer Immunotherapy™ (ACI) programs aim to reach practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals who wish to learn the basic principles of cancer immunotherapy and the most up-to-date clinical data for these treatments, in a multitude of disease states/therapeutic areas, in order to inform and integrate into their own clinical practice. In-training oncologists and hospital administrators will also find the program beneficial.

Case Study Submission Information

As part of the program, registrants are encouraged to submit case studies for expert review during the case study panel concluding the program. If you are interested in taking advantage of this opportunity, please review and sign the linked case study guidelines, and return your case study and signed guidelines to education@sitcancer.org.

Accreditation Information

Joint Accreditation Statement

thumbnail image In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and the Society for Immunotherapy of Cancer (SITC). PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC)

Successful ABIM_Logo.jpgcompletion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Physician Continuing Medical Education

PACE designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

PACE designates this continuing education activity for 3.75 contact hour(s) (0.375 CEUs) of the Accreditation Council for Pharmacy Education.

Continuing Nursing Education

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 3.75 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.

Disclosures and ADA Info

Disclosure of Conflicts of Interest

PACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact SITC Staff prior to the live event at (414) 271-2456 or via email education@sitcancer.org.

Avoid Fraudulent ACI Websites

Recently, the SITC office received communication about a fraudulent registration website for one of our ACI programs. To help ensure others don’t mistakenly register on an unauthorized, third-party website, we're proactively informing you to ensure you’re able to safely register for the event through the official SITC website, and so that you can confirm the communication you receive is truly from SITC.

All official forthcoming ACI registration information will come from an email address ending in @sitcancer.org. If you have any questions, please contact the SITC office at events@sitcancer.org or 414-271-2456.